Get more Mail & Guardian
Subscribe or Login

Madiba opera producer: R2.86m is ‘not enough’

The more than R2-million grant allocated by the National Lotteries Board of South Africa (NLB) is too little to cover the costs of a stage play about the life of former president Nelson Mandela, a producer said on Tuesday.

“The amount [R2.86-million] is not enough to cover the costs for the show and tours. We had no choice but to postpone it and find other avenues to raise funding,” said producer Unathi Mtirara, who is also Mandela’s grandnephew.

The NLB paid out the R2.86-million on Monday.

The opera play, titled Madiba: The African Opera, tells the early life of the anti-apartheid icon who died last year.

Mtirara said the NLB had agreed to grant the R11.8-million requested by the producers of the show in partnership with the African Cultural Organisation of South Africa (Acosa).

Funding U-turn
“Two weeks ago, we received correspondence from the NLB. They had made a U-turn and said that the original amount would be cut to R2-million,” said Mtirara. “We have a cast of over 200 people. The R2-million covers only the cost for the three shows we did at Pretoria’s State Theatre, hence the postponement.”

The show was supposed to move from Pretoria to Qunu in the Eastern Cape before touring South Africa and then moving overseas.

On Monday, NLB spokesperson Sershan Naidoo denied that the board had approved Mtirara’s request for R11.8-million and then decided to reduce the amount. “We deal with written contracts and not verbal agreements. The contract signed by the producers and Acosa states clearly that R2.86-million was agreed upon and approved.”

Naidoo said the board was not in a position to fund the entire amount because of a limited budget.

Kutlwano Masote, the musical director of the production, said the cast and crew would be paid for the three shows that took place in Pretoria.

“We want to thank the cast, crew and all suppliers who continued to work tirelessly over the weekend with the knowledge that they would only be paid when funding came in,” Masote said. – Sapa

Subscribe for R500/year

Thanks for enjoying the Mail & Guardian, we’re proud of our 36 year history, throughout which we have delivered to readers the most important, unbiased stories in South Africa. Good journalism costs, though, and right from our very first edition we’ve relied on reader subscriptions to protect our independence.

Digital subscribers get access to all of our award-winning journalism, including premium features, as well as exclusive events, newsletters, webinars and the cryptic crossword. Click here to find out how to join them and get a 57% discount in your first year.

Sapa
Guest Author

Related stories

WELCOME TO YOUR M&G

If you’re reading this, you clearly have great taste

If you haven’t already, you can subscribe to the Mail & Guardian for less than the cost of a cup of coffee a week, and get more great reads.

Already a subscriber? Sign in here

Advertising

Subscribers only

Data shows EFF has lower negative sentiment online among voters...

The EFF has a stronger online presence than the ANC and Democratic Alliance

Hawkish Reserve Bank sees South Africa edge towards a rates...

Analysts say the Reserve Bank could start tightening monetary policy as early as next month

More top stories

Data shows EFF has lower negative sentiment online among voters...

The EFF has a stronger online presence than the ANC and Democratic Alliance

Greenpeace investigation exposes countries trying to dilute climate report

Greenpeace team says it has obtained leaked records of countries asking scientists to water down upcoming scientific report on climate change

Zondo responds to Fraser’s objection to his nomination as chief...

The deputy chief justice said all the former spy boss had to do to respond to bombshell testimony implicating him in state capture was to apply for a turn to testify

Immunocompromised finally prioritised for Covid-19 booster shots

Organ recipients are at greater risk of death from Covid-19, while waiting lists for transplants grow
Advertising

press releases

Loading latest Press Releases…
×